Genomics analysis of leukaemia predisposition in X‐linked agammaglobulinaemia
Genomics analysis of leukaemia predisposition in X‐linked agammaglobulinaemia
复制标题
X连锁无丙种球蛋白血症患者白血病易感性的基因组学分析
DOI:
10.1111/bjh.17459
复制
发表时间:
2021
影响因子:
6.5
通讯作者:
H.
中科院分区:
文献类型:
--
作者:
Nishimura;A. Naruto;T. Miyamoto;S. Grigg;A. Bosco;J. J. Hoshino;A. Amano;K. Iwamoto;S. Hirayama;M. Migita;M. Ohara;O. Takagi;M. Morio;T. van Zelm;M. C. Kanegane;H.
Abstract BCP-ALL of the XLA patients did not show a distinctive methylation profile. X-linked agammaglobulinemia, Bruton's tyrosine kinase, acute lymphoblastic leukemia, acute megakaryoblastic leukemia, tumor suppressor Keywords: X-linked agammaglobulinemia; Bruton's tyrosine kinase; acute lymphoblastic leukemia; acute megakaryoblastic leukemia; tumor suppressor EN X-linked agammaglobulinemia Bruton's tyrosine kinase acute lymphoblastic leukemia acute megakaryoblastic leukemia tumor suppressor 1277 1281 5 06/18/21 20210615 NES 210615 X-linked agammaglobulinemia (XLA) is an inborn error of immunity caused by pathogenic variants in I Bruton's tyrosine kinase i (I BTK i). Future studies in which many patients with XLA with leukemia are enrolled may be able to clarify the more detailed characteristics of leukaemic cells in XLA.[Extracted from the article]Copyright of British Journal of Haematology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Copyright applies to all Abstracts.